Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆
Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426009142?dgcid=rss_sd_all
Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426009142?dgcid=rss_sd_all
“Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆.” Annals of Oncology.
@article{article93201,
title = {Multimodal artificial intelligence prediction of abiraterone efficacy in two STAMPEDE phase III trials of nonmetastatic very high-risk prostate cancer☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426009142?dgcid=rss_sd_all}
}